Pfizer dismissed from US states' drug price-fixing lawsuit

Pfizer has been dismissed from a lawsuit filed by several US states regarding allegations of drug price-fixing. The legal action, which targeted the pharmaceutical company for its role in inflating medication costs, did not result in the company remaining a defendant in the proceedings. This judicial decision removes Pfizer from the specific litigation brought forward by the state authorities concerning the coordinated manipulation of drug pricing within the United States healthcare market.